开放肝切除加速康复外科中急性疼痛方案保留镇痛并减少阿片类药物用量
该前瞻性研究纳入180例开放肝切除术患者,比较传统策略(pre-ERAS,n=60)与综合ERAS路径(n=120)的术后镇痛终点。ERAS组在24、48、72小时吗啡当量需求显著降低且24小时疼痛评分更低;ERAS内接受硬膜外镇痛者较未接受者24、48小时阿片需求更少、疼痛评分更优,其他术后终点相似。
要点
- ERAS路径较传统策略显著降低开放肝切除术后24、48、72小时阿片需求并改善24小时疼痛评分。
- ERAS内硬膜外镇痛进一步减少24、48小时阿片需求并优化24、48小时疼痛控制。
- 硬膜外与非硬膜外组液体供给、临床显著低血压发生率及住院时间相似。
核心结论
- 新型开放肝切除ERAS方案在不牺牲充分镇痛的前提下成功减少围术期阿片依赖。
- ERAS内应用硬膜外可进一步降低阿片需求并优化疼痛控制且不增加并发症。
- 硬膜外应继续作为肝切除ERAS方案的组成部分。
研究设计与样本
- 前瞻性收集并分析2013年11月至2016年3月连续180例开放肝切除术患者的术后镇痛终点。
- 2014年7月前手术者采用传统策略(pre-ERAS,n=60),2014年7月1日后手术者采用综合围术期ERAS路径(ERAS,n=120)。
主要发现
- ERAS组较pre-ERAS组24小时吗啡当量中位数10.0 vs 116.0 mg(P<0.001)、48小时10.1 vs 85.4 mg(P<0.001)、72小时2.5 vs 60.0 mg(P<0.001)显著降低。
- ERAS组24小时数字疼痛评分4.1±1.6 vs 5.1±1.8,其他时间点评分相似。
- ERAS内硬膜外组(n=87)较非硬膜外组(n=33)24小时吗啡当量中位数2.7 vs 65.0 mg(P<0.001)、48小时8.0 vs 50.0 mg(P<0.001)显著降低,72小时1.3 vs 4.5 mg(P=0.56)无差异。
- ERAS内硬膜外组24小时视觉模拟评分3.8±1.3 vs 5.0±1.8(P<0.001)、48小时3.4±1.8 vs 4.7±1.9(P=0.001)更优。
- 硬膜外与非硬膜外组液体供给、临床显著低血压发生率及住院时间相似。
临床怎么用
- 开放肝切除可实施以多模式镇痛为核心的ERAS路径以减少阿片用量并维持镇痛。
- ERAS框架内可考虑硬膜外镇痛以进一步降低阿片需求并改善早期疼痛评分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enhanced recovery after surgery (ERAS) pathways are designed to restore baseline physiology, mitigate surgical stressors, and hasten recovery. Paramount to this approach is optimal pain control through multimodal analgesia and limiting reliance on opioid-based medications. Recent studies have fostered growing controversy surrounding the use of epidural analgesia in the ERAS setting, especially for higher-risk procedures. We examine the analgesic end points associated with the use of epidural within the ERAS framework for open hepatectomy. METHODS: From November 2013 through March 2016, postoperative analgesic end points including daily morphine equivalent administration and self-reported pain scores were prospectively collected and analyzed for 180 consecutive patients scheduled for open hepatectomy. Patients whose surgeries performed prior to July 2014 were managed using traditional strategy (pre-ERAS, n = 60), and those after July 1 underwent a comprehensive perioperative ERAS pathway (ERAS, n = 120). RESULTS: Patients managed using the ERAS pathway had a significant reduction in morphine equivalent requirements at 24 hours (median, 10.0 vs 116.0 mg; P < 0.001), 48 hours (median, 10.1 vs 85.4 mg; P < 0.001), and 72 hours (median, 2.5 vs 60.0 mg; P < 0.001) compared with pre-ERAS counterparts with a reduction in average pain scores at 24 hours (numeric pain rating scale, 4.1 ± 1.6 vs 5.1 ± 1.8) and similar scores at other time points. Within ERAS, patients who received epidural (n = 87) required significantly less morphine equivalents at 24 hours (median, 2.7 vs 65.0 mg; P < 0.001) and 48 hours (median, 8.0 vs 50.0 mg; P < 0.001) but not at 72 hours (median, 1.3 vs 4.5 mg; P = 0.56), as well as improved pain scores at 24 hours (visual analog scale score, 3.8 ± 1.3 vs 5.0 ± 1.8; P < 0.001) and 48 hours (3.4 ± 1.8 vs 4.7 ± 1.9; P = 0.001) compared with those who did not receive epidural (n = 33). Other associated postoperative end points including provision of fluids, rates of clinically significant hypotension, and lengths of stay between epidural and nonepidural groups were similar. CONCLUSIONS: A novel ERAS protocol for open hepatectomy successfully reduced reliance on perioperative opioids without expensing adequate analgesia compared with traditional care. Patients within ERAS benefitted from application of epidural, which further reduced opioid requirements and optimized pain control without increasing complication rates. Epidurals should remain an integral part of ERAS protocols for liver resection surgery.
引用
- Grant MC, Sommer PM, He C, et al. Preserved Analgesia With Reduction in Opioids Through the Use of an Acute Pain Protocol in Enhanced Recovery After Surgery for Open Hepatectomy. Reg Anesth Pain Med. 2017. PMID: 28525409. doi:10.1097/AAP.0000000000000615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。